1479713317-hypocalcemia low calcium .ppt

gnanshreedave 35 views 52 slides Jul 30, 2024
Slide 1
Slide 1 of 52
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52

About This Presentation

Hypocalcemic states


Slide Content

HYPOCALCEMIA

Normal values
Total plasma or serum calcium :
8.5 –10.5 mg/dl
Ionized calcium :
4.6 –5.3 mg/dl
Adjusted Sr. Calcium levels
= 8 + 0.8(4-Sr.Alb)

A) B)
C) D)
Which of these hand posturing is
seen in hypocalcemia ?

CLINICAL FEATURES
•ACUTE PRESENTATION :
NEUROMUSCULAR IRRITABILITY
•TETANY
1)APPARENT
2)LATENT

TETANY
•APPARENT
General fatigue and muscle weakness
Twitching in muscles
Paresthesia & Numbness
Circumoral Paresthesia & peripheral tingling
Muscle cramps
Carpopedal spasms

TETANY
•LATENT

•Trousseau sign/ Main de accoucheur sign
BP cuff > 15 mmhg above SBP
•Extension of elbow
•Flexion wrist & MCP jt
•Extension of IP jt
•Adduction of fingers
•Chvostek sign
facial spasms/twitching produced by lightly
tapping over the facial nerve just in front of
the ear on masseter near angle of mandible .

CVS changes
•ECG : Prolonged
QTc interval
(> 12 small boxes /
0.48 sec)
•Dysarrythmias
•Hypotension
•Congestive Heart
Failure

CNS manifestations
•Emotional disturbances : irritability,
depression
•GTCS
•Papilloedema, pseudotumor cerebri (Benign
intracranial Hypertension)
•Cerebral calcifications
•Altered mental status
•coma.
FAHR SYNDROME

EVALUATION
•Serum Albumin levels
•Serum pH
•Serum Magnesium levels
•Serum Phosphorous levels
•Serum iPTH levels

•Albuminis the major reservoir of protein-bound calcium.
•Disorders that alter plasma pH or serum albumin
concentrationmust be considered when circulating calcium
concentrations are being evaluated.
•The fraction of ionized calcium is inversely related to plasma
pH; alkalosiscan precipitate hypocalcemia by lowering
ionized calcium without changing total serum calcium.
•Alkalosis may result from hyperpnea caused by anxiety or
from hyperventilation related to physical exertion.
ALBUMIN, pH & CALCIUM

•A decrease in albumin concentration of 1 g/dl results in a
decrease in protein-bound and hence total calcium
concentration of about 0.8 mg/dl.
•Binding of calcium to albumin is strongly pH-dependent
between pH 7 and pH 8; an acute increase or decrease in pH
of 0.1 pH units will increase or decrease, respectively, protein
bound calcium by about 0.12 mg/dl.
•Thus, in hypocalcemic patients with metabolic acidosis, rapid
correction of acidemia with sodium bicarbonate can
precipitate tetany, due to increased binding of calcium to
albumin and a consequent decrease in the ionized calcium
concentration.
ALBUMIN, pH & CALCIUM

•Hypoproteinemiamay lead to a false
suggestion of hypocalcemiabecause the
serum total calcium level is low even though
the ionized Ca
2+
remains normal.
•Magnesium causes reversible impairment of
PTH . It is the most common & correctable
cause of hypocalcemia
•It is best to measure serum ionized calcium if
hypocalcemiaor hypercalcemiais suspected.
ALBUMIN, pH & CALCIUM

DIAGNOSIS CALCIUMPHOSPHOROUSPTH
TRUE
HYPOPARATHYROIDISM
LOW HIGH LOW
PSEUDO
HYPOPARATHYROIDISM
LOW HIGH HIGH
LYSIS,AKI, CKD LOW HIGH NORMAL
VITAMIN D DEFICIENCYLOW LOW LOW
3
O
HYPERPARATHYROIDISM
HIGH HIGH HIGH
CALCIUM , PHOSPHOROUS & PTH

ETIOLOGIC CLASSIFICATION OF
HYPOCALCEMIA
•PARATHYROID HORMONE DEFICIENCY
•PARATHYROID HORMONE RECEPTOR DEFECTS
(PSEUDOHYPOPARATHYROIDISM)
•MITOCHONDRIAL DNA MUTATIONS
•MAGNESIUM DEFICIENCY
•EXOGENOUS INORGANIC PHOSPHATE EXCESS
•VITAMIN D DEFICIENCY

PARATHYROID HORMONE
DEFICIENCY
•Aplasia or hypoplasia of parathyroids
•Suppression of neonatal PTH secretion due to
maternal hyperparathyroidism
•Preproparathyroid hormone gene mutation
•Ca
2+
-sensing receptor activating mutation
•Autoimmune parathyroiditis
•Infiltrative lesions

•Primary hypoparathyroidismcauses
hypocalcemia, but does not cause rickets.

Etiology of primary
hypoparathyroidism
•Congenital malformation (e.g., DiGeorge syndrome
or other complex syndromes) resulting from
developmental abnormalities of the third and fourth
branchial arches
•Surgical procedures, such as thyroidectomy or
parathyroidectomy, in which parathyroid tissue is
removed either deliberately or as a complication of
surgery for another goal
•Autoimmunity (autoimmune polyglandular syndrome
type 1), which may destroy the parathyroid gland

Pseudohypoparathyroidism
•Pseudohypoparathyroidismmay occur in one
of four forms, all with hypocalcemia and
hyperphosphatemia.

Pseudohypoparathyroidism
•Type Ia-an abnormality of the G
sαprotein linking the PTH
receptor to adenylate cyclase; biologically active PTH is
secreted in great quantities but does not stimulate its
receptor
•Type Ib-normal phenotype, normal G
sαwith abnormalities in
the production of adenylate cyclase
•Type Ic-abnormal phenotype, normal production of adenylate
cyclase, but a distal defect eliminates the effects of PTH
•Type II-normal phenotype, normal production of adenylate
cyclase, with a postreceptor defect, close to type Ib

•Pseudohypoparathyroidism is an autosomal
dominant condition that may present at birth or
later.
•Other clinical manifestationsof
pseudohypoparathyroidism associated with Albright
hereditary osteodystrophyinclude short stature,
stocky body habitus, round facies, short fourth and
fifth metacarpals, calcification of the basal ganglia,
subcutaneous calcification, and, often,
developmental delay.

•Albright hereditary osteodystrophy may be
inherited separately so that a patient may
have a normal appearance with hypocalcemia
or may have the Albright hereditary
osteodystrophy phenotype with normal serum
calcium, phosphate, PTH, and response to
PTH.

•During the first 3 days after birth, serum
calcium concentrations normally decline in
response to withdrawal of the maternal
calcium supply via the placenta.
•Sluggish PTH response in a neonate may result
in a transient hypocalcemia.

•Hypocalcemia caused by attenuated PTH
release is found in infants of mothers with
hyperparathyroidism and hypercalcemia; the
latter suppresses fetal PTH release, causing
transient hypoparathyroidismin the neonatal
period.

•Normal serum magnesium concentrations are
required for normal parathyroid gland
function and action.
•Hypomagnesemiamay cause a secondary
hypoparathyroidism, which responds poorly to
therapies other than magnesium replacement.

•Neonatal tetanyis most often noted in
premature or asphyxiated infants and infants
of diabetic mothers.

•Excessive phosphate retention, as occurs in
renal failure, also produces hypocalcemia.

•The etiologyof hypocalcemia usually can be
discerned by combining features of the clinical
presentation with determinations of serum
ionized calcium, phosphate, alkaline
phosphatase, PTH (preferably at a time when
the calcium is low), magnesium, and albumin.

•If the PTH concentration is not elevated
appropriately relevant to low serum calcium,
hypoparathyroidism (transient, primary, or
caused by hypomagnesemia) is present.

•Vitamin D stores can be estimated by
measuring serum 25-hydroxyvitamin D.

•Renal function is assessed by a serum
creatinine measurement or determination of
creatinine clearance.

Important Physiologic Changes in
Bone and Mineral Diseases
•Condition CalciumPhosphateParathyroid Hormone25(OH)D
Primary hypoparathyroidism ↓ ↑ ↓ Nl
Pseudohypoparathyroidism ↓ ↑ ↑ Nl
Vitamin D deficiency Nl(↓) ↓ ↑ ↓
Familial hypophosphatemic rickets Nl ↓ Nl (sl↑) Nl
Hyperparathyroidism ↑ ↓ ↑ Nl
Immobilization ↑ ↑ ↓ Nl

RICKETS
•Rickets is defined as decreased or defective
bone mineralization in growing children;
osteomalaciais the same condition in adults.
•The proportion of osteoid (the organic portion
of bone) is excessive.
•As a result, the bone becomes soft and the
metaphyses of the long bones widen.

Clinical manifestations
•Most manifestations of rickets are due to
skeletal changes.
•Craniotabes
•Rachitic rosary
•Growth plate widening is also responsible for
the enlargement at the wrists and ankles.
•Harrison groove

•Very low birth weight infants have an
increased incidence of rickets of prematurity.
•In older infants, poor linear growth, bowing of
the legs on weight bearing (which can be
painful), thickening at the wrists and knees,
and prominence of the costochondral
junctions (rachitic rosary) of the rib cage
occur.
•At this stage, x-ray findings are diagnostic.

•In nutritional vitamin D deficiency, calcium is
not absorbed adequately from the intestine.
•Poor vitamin D intake (food fads or poor
maternal diet affecting breast milk vitamin D)
or avoidance of sunlight in infants exclusively
breastfedmay contribute to the development
of rickets.

•Fat malabsorption resulting from
hepatobiliary disease (biliary atresia, neonatal
hepatitis) or other causes (cystic fibrosis) also
may produce vitamin D deficiency because
vitamin D is a fat-soluble vitamin.

•Defects in vitamin D metabolism by the kidney
(renal failure, autosomal recessive deficiency
of 1α-hydroxylation, vitamin D-dependent
rickets) or liver (defect in 25-hydroxylation)
also can cause rickets.

•In familial hypophosphatemic rickets, the
major defect in mineral metabolism is failure
of the kidney to reabsorb filtered phosphate
adequately so that serum phosphate
decreases, and urinary phosphate is high.
•The diagnosisof this X-linked disease usually
is made within the first few years of life.
•Disease typically is more severe in males.

•The etiologyof rickets usually can be
determined by assessment of the mineral and
vitamin D status(25-hydroxyvitamin D < 8
ng/mL suggests nutritional vitamin D
deficiency).
•Further testing of mineral balance or
measurement of other vitamin D metabolites
may be required.

•Several chemical forms of vitamin D can be
used for treatmentof the different rachitic
conditions, but their potencies vary widely.
•Required dosages depend on the condition
being treated .

•Rickets usually is treated with 1,25-
hydroxyvitamin D and supplemental calcium.
•In hypophosphatemic rickets, phosphate
supplementation (not calcium) must
accompany vitamin D therapy, which is given
to suppress secondary hyperparathyroidism.

•Adequate therapy restores normal skeletal
growth and produces resolution of the
radiographic signs of rickets.
•Nutritional rickets is treated with vitamin D in
one large dose or multiple smaller
replacement doses.
•Surgery may be required to straighten legs in
untreated patients with long-standing disease.

TREATMENT OF HYPOCALCEMIA
•IV:1 gm(10 ml) CaGluconate10 %over 10 min
•1 gm= 93 mg elemental calcium
Treatment is monitored using ECG for sinus brady
•INFUSION: 5 gmin 500 ml D5 at 1-3 mg
elemental ca/kg/hr(120 mg/hr)=30 d/min
•ORAL : Max upto2 gm/day

•Long-term treatment of hypoparathyroidism
involves administering vitamin D, preferably as
1,25-dihydroxyvitamin D, and calcium.
•Therapy is adjusted to keep the serum calcium
in the lower half of the normal range to avoid
episodes of hypercalcemia that might produce
nephrocalcinosis and to avoid pancreatitis.